乳がんスクリーニング市場：技術、製品、エンドユーザー別-2025-2030年の世界予測

乳がんスクリーニング市場は、2023年に50億1,000万米ドルと評価され、2024年には53億1,000万米ドルに達すると予測され、CAGR 6.72％で成長し、2030年には79億米ドルに達すると予測されています。

乳がんスクリーニングには、主にマンモグラム、超音波、MRIなどの方法を通じて、症状が現れる前の早期段階で乳がんを発見するように設計された医療検査が含まれます。乳がんスクリーニングの必要性は、早期発見により死亡率を低下させ、治療効果を向上させる可能性があることから強調されています。最終用途は主に40歳以上の女性であるが、認知度の向上により、より若い女性にも利用されるようになっています。主な市場成長要因としては、3DマンモグラフィやAI強調画像などの検診技術の進歩に加え、世界の意識の高まりや女性ヘルスケアへの取り組みが挙げられます。さらに、新興市場における政府の支援政策や医療インフラの改善は、大きな成長の可能性を秘めています。しかし、特に低所得地域における医療へのアクセスの格差や、検診の受診率を低下させる可能性のある過剰診断や偽陽性の潜在的リスクに関する継続的な議論など、課題も残っています。

事業成長の機会は、費用対効果の高い携帯型スクリーニング機器や、画像診断の精度を高め操作時間を短縮するAIツールの開発にあります。アクセシビリティと認知度を向上させるための戦略を駆使して未開拓市場に進出すれば、大きな配当が得られる可能性があります。遺伝的要因やライフスタイルを考慮した個別化スクリーニングアプローチの調査により、有効性と受容性が高まる可能性があります。市場情勢はダイナミックであり、技術革新と公衆衛生政策に牽引されているが、規制状況を乗り切り、社会経済的障壁に対処する必要があります。この市場の性質は競争が激しく、大手ヘルスケア企業とブティック企業が、技術力と戦略的提携によって市場の存在感を競っています。企業は、最先端技術の研究開発への投資を優先し、政府機関と戦略的に提携し、地域社会へのアウトリーチプログラムに積極的に関与して教育し、定期的な検診の受診を奨励することで、市場への全体的な浸透と持続性を確保することが推奨されます。

市場力学：急速に進化する乳がんスクリーニング市場の主要市場インサイトを公開

乳がんスクリーニング市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の女性のがん患者の増加
  • 病気に対する認識を高めるための政府の健康キャンペーン
  • スクリーニングとモニタリングのためのMRI技術の大幅な採用
• 市場抑制要因
  • 乳がんスクリーニング機器のリコール
• 市場機会
  • AIがサポートするがん検診用3Dマンモグラフィ検診の出現
  • 先進免疫療法の採用
• 市場の課題
  • 誤診の潜在的リスク

ポーターの5つの力：乳がんスクリーニング市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：乳がんスクリーニング市場における外部からの影響の把握

外部マクロ環境要因は、乳がんスクリーニング市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析乳がんスクリーニング市場における競合情勢の把握

乳がんスクリーニング市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス乳がんスクリーニング市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、乳がんスクリーニング市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨乳がんスクリーニング市場における成功への道筋を描く

乳がんスクリーニング市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で女性のがん症例が増加
    • 病気の認識を高める政府の健康キャンペーン
    • スクリーニングとモニタリングのためのMRI技術の大幅な導入。
  • 抑制要因
    • 乳がんスクリーニングデバイスのリコール
  • 機会
    • がん検診におけるAI支援型3Dマンモグラフィー検査の登場
    • 先進免疫療法の導入
  • 課題
    • 誤った結果が出る可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 乳がんスクリーニング市場：技術別

• イオン化乳房画像技術
  • 3D乳房トモシンセシス
  • アナログマンモグラフィー
  • コーンビームコンピュータ断層撮影（CBCT）
  • 造影マンモグラフィー（CEM）
  • フルフィールドデジタルマンモグラフィー（FFDM）
  • 分子乳房イメージング/乳房特異的ガンマイメージング（MBI/BSGI）
  • 陽電子放出マンモグラフィー（PEM）
  • 陽電子放出断層撮影およびコンピュータ断層撮影（PET-CT）
• 非電離乳房画像診断技術
  • 自動全乳房超音波検査（AWBU）
  • 乳房MRI
  • 乳房サーモグラフィー
  • 乳房超音波検査
  • 電気インピーダンストモグラフィー
  • 光学イメージング

第7章 乳がんスクリーニング市場：製品別

• アクセサリー
• 乳房画像診断システム
• ソフトウェアとサービス

第8章 乳がんスクリーニング市場：エンドユーザー別

• 乳がんケアセンター
• 画像診断センター
• 病院・クリニック

第9章 南北アメリカの乳がんスクリーニング市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の乳がんスクリーニング市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの乳がんスクリーニング市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• AstraZeneca plc
• Bayer AG
• Becton, Dickinson and Company
• Carestream Health, Inc.
• Danaher Corporation
• Exact Sciences Corporation
• F. Hoffmann-La Roche Ltd
• Fujifilm Holdings Corporation
• GE HealthCare Technologies Inc.
• GlaxoSmithKline plc
• Hologic, Inc.
• Koning Health
• Koninklijke Philips N.V.
• Myriad Genetics, Inc.
• NanoString Technologies, Inc.
• NIRAMAI Health Analytix Private Limited
• Novartis AG
• Oncocyte Corporation
• OncoStem Diagnostics Pvt. Ltd
• Pfizer Inc.
• Prelude Corporation
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Syantra Inc.
• Vayyar Imaging, Ltd.

LIST OF FIGURES

• FIGURE 1. BREAST CANCER SCREENING MARKET RESEARCH PROCESS
• FIGURE 2. BREAST CANCER SCREENING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BREAST CANCER SCREENING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BREAST CANCER SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BREAST CANCER SCREENING MARKET DYNAMICS
• TABLE 7. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY 3D BREAST TOMOSYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ANALOG MAMMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONE-BEAM COMPUTED TOMOGRAPHY (CBCT), BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY CONTRAST-ENHANCED MAMMOGRAPHY (CEM), BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY FULL-FIELD DIGITAL MAMMOGRAPHY (FFDM), BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY MOLECULAR BREAST IMAGING/BREAST SPECIFIC GAMMA IMAGING (MBI/BSGI), BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY POSITRON EMISSION MAMMOGRAPHY (PEM), BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY (PET-CT), BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY AUTOMATED WHOLE-BREAST ULTRASOUND (AWBU), BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST MRI, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST THERMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST ULTRASOUND, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ELECTRIC IMPEDANCE TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY OPTICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST IMAGING SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY BREAST CARE CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL BREAST CANCER SCREENING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 41. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 42. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 47. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 48. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. BRAZIL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 50. CANADA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 51. CANADA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 52. CANADA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 53. CANADA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. CANADA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. MEXICO BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES BREAST CANCER SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 72. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 77. CHINA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. CHINA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 79. CHINA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 80. CHINA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. CHINA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 82. INDIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 83. INDIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 84. INDIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 85. INDIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. INDIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 87. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 88. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 89. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 90. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 92. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 93. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 94. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 95. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. JAPAN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 97. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 99. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 100. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. MALAYSIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 102. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 103. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 104. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 105. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. PHILIPPINES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 107. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 108. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 109. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 110. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. SINGAPORE BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 112. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 113. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 114. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 115. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. SOUTH KOREA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 117. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 118. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 119. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 120. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. TAIWAN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 122. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 124. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 125. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. THAILAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 127. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 128. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 129. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 130. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. VIETNAM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 132. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 133. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 134. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 135. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 137. EUROPE, MIDDLE EAST & AFRICA BREAST CANCER SCREENING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 138. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 140. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 141. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. DENMARK BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 143. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 144. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 145. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 146. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. EGYPT BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 148. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 149. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 150. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 151. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 152. FINLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 153. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 154. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 155. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 156. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. FRANCE BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 158. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 160. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 161. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 162. GERMANY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 163. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 164. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 165. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 166. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. ISRAEL BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 168. ITALY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 169. ITALY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 170. ITALY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 171. ITALY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 172. ITALY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 173. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 174. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 175. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 176. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. NETHERLANDS BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 178. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 180. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 181. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 182. NIGERIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 183. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 184. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 185. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 186. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. NORWAY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 188. POLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 189. POLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 190. POLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 191. POLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 192. POLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 193. QATAR BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 194. QATAR BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 195. QATAR BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 196. QATAR BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 197. QATAR BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 198. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 199. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 200. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 201. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 202. RUSSIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 203. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 204. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 205. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 206. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 207. SAUDI ARABIA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 208. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 209. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 210. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 211. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 212. SOUTH AFRICA BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 213. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 214. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 215. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 216. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 217. SPAIN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 218. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 219. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 220. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 221. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 222. SWEDEN BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 223. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 224. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 225. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 226. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 227. SWITZERLAND BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 228. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 229. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 230. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 231. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 232. TURKEY BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 233. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 234. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 235. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 236. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 237. UNITED ARAB EMIRATES BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 238. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 239. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 240. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY NON-IONIZING BREAST IMAGING TECHNOLOGIES, 2018-2030 (USD MILLION)
• TABLE 241. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 242. UNITED KINGDOM BREAST CANCER SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
• TABLE 243. BREAST CANCER SCREENING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 244. BREAST CANCER SCREENING MARKET, FPNV POSITIONING MATRIX, 2023

The Breast Cancer Screening Market was valued at USD 5.01 billion in 2023, expected to reach USD 5.31 billion in 2024, and is projected to grow at a CAGR of 6.72%, to USD 7.90 billion by 2030.

Breast cancer screening involves medical tests designed to detect breast cancer at an early stage before any symptoms appear, primarily through methods like mammograms, ultrasound, and MRI. The necessity of breast cancer screening is underscored by its potential to reduce mortality rates through early detection, which improves treatment efficacy. Its applications span hospitals, diagnostic laboratories, and specialty clinics, with end-use mainly among women aged 40 and above, though increasing accessibility extends these services to younger women due to rising awareness. Key market growth factors include advancements in screening technology, such as 3D mammography and AI-enhanced imaging, along with heightened awareness and female healthcare initiatives globally. Moreover, supportive governmental policies and improved healthcare infrastructure in emerging markets present substantial growth potential. However, challenges remain, including disparities in access to care, particularly in low-income regions, and the ongoing debate about the potential risks of overdiagnosis or false positives, which may undermine screening uptake.

Opportunities for business growth lie in developing cost-effective, portable screening devices and AI tools that enhance imaging accuracy and reduce operational time. Expansion into untapped markets with tailored strategies to improve accessibility and awareness could yield significant dividends. Research into personalized screening approaches, considering genetic and lifestyle factors, might enhance effectiveness and acceptance. The breast cancer screening market is dynamic, driven by technological innovation and public health policies, but it requires navigating regulatory landscapes and addressing socio-economic barriers. The nature of this market is highly competitive, with established healthcare giants and boutique firms vying for market presence, largely dictated by technological prowess and strategic alliances. Companies are recommended to prioritize investment in R&D for cutting-edge technologies, strategically collaborate with governmental agencies for better reach, and actively engage in community outreach programs to educate and encourage regular screening adherence, ensuring holistic market penetration and sustenance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Breast Cancer Screening Market

The Breast Cancer Screening Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing cases of cancer in women globally
  • Government health campaign to raise disease awareness
  • Significant adoption of MRI techniques for screening and monitoring.
• Market Restraints
  • Breast cancer screening device recalls
• Market Opportunities
  • Emergence of AI-supported 3D mammogram screening for cancer screening
  • Adoption of advanced Immunotherapy
• Market Challenges
  • Potential risk of false results

Porter's Five Forces: A Strategic Tool for Navigating the Breast Cancer Screening Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Breast Cancer Screening Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Breast Cancer Screening Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Breast Cancer Screening Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Breast Cancer Screening Market

A detailed market share analysis in the Breast Cancer Screening Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Breast Cancer Screening Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Breast Cancer Screening Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Breast Cancer Screening Market

A strategic analysis of the Breast Cancer Screening Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Breast Cancer Screening Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca plc, Bayer AG, Becton, Dickinson and Company, Carestream Health, Inc., Danaher Corporation, Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Fujifilm Holdings Corporation, GE HealthCare Technologies Inc., GlaxoSmithKline plc, Hologic, Inc., Koning Health, Koninklijke Philips N.V., Myriad Genetics, Inc., NanoString Technologies, Inc., NIRAMAI Health Analytix Private Limited, Novartis AG, Oncocyte Corporation, OncoStem Diagnostics Pvt. Ltd, Pfizer Inc., Prelude Corporation, Quest Diagnostics Incorporated, Siemens Healthineers AG, Syantra Inc., and Vayyar Imaging, Ltd..

Market Segmentation & Coverage

This research report categorizes the Breast Cancer Screening Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technology, market is studied across Ionizing Breast Imaging Technologies and Non-ionizing Breast Imaging Technologies. The Ionizing Breast Imaging Technologies is further studied across 3D Breast Tomosynthesis, Analog Mammography, Cone-Beam Computed Tomography (CBCT), Contrast-Enhanced Mammography (CEM), Full-Field Digital Mammography (FFDM), Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI), Positron Emission Mammography (PEM), and Positron Emission Tomography and Computed Tomography (PET-CT). The Non-ionizing Breast Imaging Technologies is further studied across Automated Whole-Breast Ultrasound (AWBU), Breast MRI, Breast Thermography, Breast Ultrasound, Electric Impedance Tomography, and Optical Imaging.
• Based on Product, market is studied across Accessories, Breast Imaging Systems, and Software & Services.
• Based on End User, market is studied across Breast Care Centers, Diagnostic Imaging Centers, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing cases of cancer in women globally
    • 5.1.1.2. Government health campaign to raise disease awareness
    • 5.1.1.3. Significant adoption of MRI techniques for screening and monitoring.
  • 5.1.2. Restraints
    • 5.1.2.1. Breast cancer screening device recalls
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of AI-supported 3D mammogram screening for cancer screening
    • 5.1.3.2. Adoption of advanced Immunotherapy
  • 5.1.4. Challenges
    • 5.1.4.1. Potential risk of false results
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Breast Cancer Screening Market, by Technology

• 6.1. Introduction
• 6.2. Ionizing Breast Imaging Technologies
  • 6.2.1. 3D Breast Tomosynthesis
  • 6.2.2. Analog Mammography
  • 6.2.3. Cone-Beam Computed Tomography (CBCT)
  • 6.2.4. Contrast-Enhanced Mammography (CEM)
  • 6.2.5. Full-Field Digital Mammography (FFDM)
  • 6.2.6. Molecular Breast Imaging/Breast Specific Gamma Imaging (MBI/BSGI)
  • 6.2.7. Positron Emission Mammography (PEM)
  • 6.2.8. Positron Emission Tomography and Computed Tomography (PET-CT)
• 6.3. Non-ionizing Breast Imaging Technologies
  • 6.3.1. Automated Whole-Breast Ultrasound (AWBU)
  • 6.3.2. Breast MRI
  • 6.3.3. Breast Thermography
  • 6.3.4. Breast Ultrasound
  • 6.3.5. Electric Impedance Tomography
  • 6.3.6. Optical Imaging

7. Breast Cancer Screening Market, by Product

• 7.1. Introduction
• 7.2. Accessories
• 7.3. Breast Imaging Systems
• 7.4. Software & Services

8. Breast Cancer Screening Market, by End User

• 8.1. Introduction
• 8.2. Breast Care Centers
• 8.3. Diagnostic Imaging Centers
• 8.4. Hospitals & Clinics

9. Americas Breast Cancer Screening Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Breast Cancer Screening Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Breast Cancer Screening Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AstraZeneca plc
• 2. Bayer AG
• 3. Becton, Dickinson and Company
• 4. Carestream Health, Inc.
• 5. Danaher Corporation
• 6. Exact Sciences Corporation
• 7. F. Hoffmann-La Roche Ltd
• 8. Fujifilm Holdings Corporation
• 9. GE HealthCare Technologies Inc.
• 10. GlaxoSmithKline plc
• 11. Hologic, Inc.
• 12. Koning Health
• 13. Koninklijke Philips N.V.
• 14. Myriad Genetics, Inc.
• 15. NanoString Technologies, Inc.
• 16. NIRAMAI Health Analytix Private Limited
• 17. Novartis AG
• 18. Oncocyte Corporation
• 19. OncoStem Diagnostics Pvt. Ltd
• 20. Pfizer Inc.
• 21. Prelude Corporation
• 22. Quest Diagnostics Incorporated
• 23. Siemens Healthineers AG
• 24. Syantra Inc.
• 25. Vayyar Imaging, Ltd.